[Ip-health] The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A New Liver Cancer Drug

Kim Treanor kim.treanor at keionline.org
Tue Aug 8 12:24:46 PDT 2017


http://www.huffingtonpost.com/entry/salubris-liver-cancer-drug_us_5989d2d3e4b0d793738a5f1e?9lr

The U.S. Is Quietly Giving A Chinese Billionaire A Monopoly On A New Liver
Cancer Drug
Alexander Kaufman in the Huffington Post on 8 August 2017

The federal government plans to give the exclusive license for a new liver
cancer drug to a pharmaceutical company owned by China’s 63rd-richest man,
HuffPost has learned.

[snip]

The proposal comes amid growing public backlash to deals that give
pharmaceutical companies monopolies on drugs and vaccines developed through
taxpayer-funded research without requiring them to sell the drugs back to
Americans at a reasonable price.

[snip]

“Is anyone in the White House paying any attention to these NIH patent
licenses?” Jamie Love, the director of KEI, asked in an email to HuffPost
on Tuesday. “The NIH wants to turn this over, life of patent, with zero
agreements on the price, to Ye Chenghai, the former mayor of Shenzhen, in
total secrecy as regards every important element of the license.”


-- 


Kim Treanor
Knowledge Ecology International
kim.treanor at keionline.org
tel.: +1.202.332.2670



More information about the Ip-health mailing list